Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded by scientists, physicians, entrepreneurs, and investors, Vida Ventures, LLC is a life sciences investment firm with a focus on therapeutics. The firm operates from multiple U.S. locations, including Los Angeles, Fort Worth, Boston, and New York, managing approximately $1.8 billion in assets. Vida Ventures employs a flexible investment strategy to support companies across various stages of development.
Vida Ventures invests in the life sciences sector, specifically targeting therapeutics. They back companies at all stages, from early startups to established commercial enterprises, leveraging their extensive experience to support the entire continuum of discovery and development.
Notable portfolio companies include A2 Biotherapeutics, Aktis Oncology, Allogene Therapeutics, Halda Therapeutics, Kyverna Therapeutics, Protego Biopharma, and Scorpion Therapeutics.
To pitch Vida Ventures, email info@vidaventures.com with your deck for consideration.
As of recent updates, Vida Ventures congratulated Aktis Oncology on its public market entry and announced the launch of Poplar Therapeutics, which secured $50 million in Series A funding for a new class of anti-IgE therapy.
Yes, Vida Ventures often leads investment rounds, particularly in early-stage companies within the life sciences sector.
Vida Ventures is open to follow-on investments, supporting portfolio companies as they progress through various stages of development.
Vida Ventures manages a fund size of $1.8 billion, allowing for significant investments across multiple stages.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.